Xavier Collazo, a DPT specialising in sports performance and rehabilitation at Tampa Bay Performance Physical Therapy, emphasises that the benefits of GLP-1 drugs must be carefully balanced against the potential risks, particularly for non-obese and non-diabetic athletes
WuMYYiangGTLiaoWTTsaiAPYChengYLChengPWet al
1,2,4,6 These events are associated with irreversible lung damage, worsening respiratory symptoms, increased risk of death, and substantial use of healthcare resources
129 Stabilized -catenin translocates to the nucleus and partners with TCF/LEF transcription factors to activate oncogenic targets, including MYC, Cyclin D1, LGR5, CD44, and ABCB1, genes that regulate proliferation, drug efflux, and stemness
Its dual-receptor action may make it a better fit for patients who need broader support with insulin response, cravings, and fat metabolism